
Please try another search
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Gregory Bailey Brown | 67 | 2016 | Independent Chairman of the Board |
Steven M. Klosk | 66 | 2014 | Independent Director |
Heidi Henson | 57 | 2022 | Independent Director |
David J. Mazzo | 66 | 2015 | President, CEO & Director |
Mohammad Azab | 69 | 2022 | Independent Director |
Cynthia Louise Flowers | 65 | 2018 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review